Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis

Muthalagu Ramanathan, MD, Pierre Teira, MD MS, Minoo Battiwalla, MDMS, A. John Barrett, MD FRCP, FRCPath, Caroline A Lindemans, MD PhD, Jeffery Auletta, MD, Kwang Woo Ahn, PhD, Min Chen, PhD, Marcie L Riches, MD MS, Michael Boeckh, MD

Blood (2014) 124 (21): 47.

https://doi.org/10.1182/blood.V124.21.47.47

Published: 2014

Journal Articles

Interleukin-2 (hrIL2) Primed T cells display Reduced Alloproliferative Capacity In Vitro Due To Induction Of FOXP3+ Regulatory Cells

Dimitra Kokkinou, MSc, Panagiota Stamou, PHD, Angeliki Vittoraki, MD, Anne-Lise De Lastic, MD, Spyros Chondropoulos, A. John Barrett, MD, FRCP, FRCPath, Alexandros Spyridonidis, MD

Blood (2013) 122 (21): 5433.

https://doi.org/10.1182/blood.V122.21.5433.5433

Published: 2013

Journal Articles

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Robert Quan Le, MD, PhD, Natasha A Jain, MD, Xin Tian, PhD, Sawa Ito, Kit Lu, MD, Janice Haggerty, RN, Debbie A Draper, RN, Kamna Chawla, MD, MS, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2013) 122 (21): 2124.

https://doi.org/10.1182/blood.V122.21.2124.2124

Published: 2013

Journal Articles

Infusion Of Donor-Derived CD19-Redirected-Virus-Specific T Cells For B-Cell Malignancies Relapsed After Allogeneic Stem Cell Transplant: A Phase I Study

Blood (2013) 122 (21): 152.

https://doi.org/10.1182/blood.V122.21.152.152

Published: 2013

Journal Articles

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Natasha A Jain, MD, Eleftheria K. Koklanaris, BSN, Kamna Chawla, MD, MS, Priyanka A Pophali, MD, Jeffrey K. Klotz, MD, Christopher S. Hourigan, MD, PhD, Bipin N. Savani, MD, Sawa Ito, MD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2012) 120 (21): 1967.

https://doi.org/10.1182/blood.V120.21.1967.1967

Published: 2012

Journal Articles

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

Zachariah A. McIver, DO, J. Joseph Melenhorst, PhD, Haiyun Zheng, Colin O. Wu, PhD, Andrew Grim, BS, Sawa Ito, MD, Irene Cho, BS, Nancy F. Hensel, BS, A. John Barrett, MD, FRCP, FRCPath

Blood (2011) 118 (21): 328.

https://doi.org/10.1182/blood.V118.21.328.328

Published: 2011

Journal Articles

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Priyanka A Pophali, MD, Kamna Chawla, MD, MS, Eleftheria K. Koklanaris, BSN, Avan Antia, Simar Chawla, Sawa Ito, MD, Jeffrey K. Klotz, MD, Robert Q. Le, MD, PhD, A. John Barrett, MD, FRCP, Minoo Battiwalla, MD, MS

Blood (2011) 118 (21): 4099.

https://doi.org/10.1182/blood.V118.21.4099.4099

Published: 2011

Journal Articles

Naïve T Cell-Derived CTL Recognize Atypical Epitopes of CMVpp65 with Higher Avidity Than CMV-Seropositive Donor-Derived CTL – a Basis for Treatment of Post-Transplant Viral Infection by Adoptive Transfer of T Cells From Virus-naïve Donors

Patrick J Hanley, Ph.D, J. Joseph Melenhorst, PhD, Phillip Scheinberg, MD, Gail J Demmler-Harrison, MD, Daniele Lilleri, MD, Giuseppe Gerna, MD, Helen E. Heslop, MD, Cliona M. Rooney, PhD, A. John Barrett, MD, FRCP, Elizabeth J Shpall, MD, Catherine M. Bollard, MD

Blood (2011) 118 (21): 3002.

https://doi.org/10.1182/blood.V118.21.3002.3002

Published: 2011

Journal Articles

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Robert Q. Le, MD, PhD, J. Joseph Melenhorst, PhD, Brenna Hill, MPhil, Sarfraz Memon, MD, Minoo Battiwalla, MD, MS, Bipin N. Savani, MD, Aarthi Shenoy, MD, Nancy F. Hensel, BS, Eleftheria K. Koklanaris, RN, BS, Keyvan Keyvanfar, BS, Frances T. Hakim, PhD, Daniel C. Douek, MD, PhD, A. John Barrett, MD, FRCP, FRCPath

Blood (2010) 116 (21): 831.

https://doi.org/10.1182/blood.V116.21.831.831

Published: 2010

Journal Articles

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Stephan Mielke, MD, Aarthi Shenoy, MD, Vicki S. Fellowes, Katayoun Rezvani, MD, PhD, Bipin N. Savani, MD, Laura Musse, Laura Wisch, Roger Kurlander, MD, Hanh Khuu, MD, Carol Boss, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 1168.

https://doi.org/10.1182/blood.V112.11.1168.1168

Published: 2008

Journal Articles

Higher Absolute NK Count on Day30 after HLA Identical Sibling Allogeneic Stem Cell Transplantation and a “Favorable KIR” Genotype Are Associated with Faster NK Maturation and Other Functional Differences.

David Z. Drew, MD, Jan Melenhorst, Ph.D, Nancy F. Hensel, Ph.D, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 2167.

https://doi.org/10.1182/blood.V112.11.2167.2167

Published: 2008

Journal Articles

Inflammatory Cytokine Levels in the Peri-Stem Cell Transplantation Period Correlate with Fluctuations in Peripheral Blood Counts but Not with Inflammation.

J. Joseph Melenhorst, PhD, Angelique Biancotto, PhD, Phillip Scheinberg, MD, Colin O. Wu, PhD, J. Philip McCoy, PhD, Priscila Scheinberg, Nancy F Hensel, A. John Barrett, MD, FRCP

Blood (2008) 112 (11): 1541.

https://doi.org/10.1182/blood.V112.11.1541.1541

Published: 2008

NARROW

Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis

Interleukin-2 (hrIL2) Primed T cells display Reduced Alloproliferative Capacity In Vitro Due To Induction Of FOXP3+ Regulatory Cells

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

Infusion Of Donor-Derived CD19-Redirected-Virus-Specific T Cells For B-Cell Malignancies Relapsed After Allogeneic Stem Cell Transplant: A Phase I Study

Post-Transplant Pulmonary Function Abnormalities Normalize in Survivors by the Second Decade After Allogeneic Stem Cell Transplantation

Low Thymic Natural Regulatory T Cell Output in the Donor Is Associated with An Increased Incidence of Extensive Chronic GvHD After T Cell Depleted Matched Sibling Stem Cell Transplantation (SCT)

Chronic Graft Versus Host Disease (GVHD) Does Not Impact Cardiovascular Risk Factors in Survivors of Allogeneic Hematopoietic Stem Cell Transplantation (SCT) up to the Second Decade Post-Transplant,

Naïve T Cell-Derived CTL Recognize Atypical Epitopes of CMVpp65 with Higher Avidity Than CMV-Seropositive Donor-Derived CTL – a Basis for Treatment of Post-Transplant Viral Infection by Adoptive Transfer of T Cells From Virus-naïve Donors

Evolution of the Donor T Cell Repertoire In Allogeneic Stem Cell Transplant Recipients In the Second Decade After Transplantation

Selective Allodepletion by TH9402-Mediated Photosensitization Results in Early Full Donor T Cell Reconstitution in the Absence of High-Grade, Acute GvHD and Is Associated with Favorable Outcome after HLA Matched Sibling SCT for Hematologic Malignancies

Higher Absolute NK Count on Day30 after HLA Identical Sibling Allogeneic Stem Cell Transplantation and a “Favorable KIR” Genotype Are Associated with Faster NK Maturation and Other Functional Differences.

Inflammatory Cytokine Levels in the Peri-Stem Cell Transplantation Period Correlate with Fluctuations in Peripheral Blood Counts but Not with Inflammation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only